Quidel nets EUA, CE Mark for Lyra Direct SARS-CoV-2 assay

By LabPulse.com staff writers

May 19, 2020 -- Quidel has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) and the CE Mark for its Lyra Direct SARS-CoV-2 assay, a new version of its Lyra real-time reverse transcription polymerase chain (RT-PCR) test that skips upfront sample extraction.

With Lyra Direct, the RNA extraction processing step is replaced by a reformulated buffer with a 10-minute heat step, saving approximately 50 minutes in processing time, according to the company. As was the case with Quidel's original Lyra SARS-CoV-2 assay, Lyra Direct can be run on seven thermocyclers, including 7500 Standard and 750 Fast (Applied Biosystems), CFX96 Touch (Bio-Rad), Rotor-Gene Q (Qiagen), LightCycler 480 and Cobas z480 (Roche), and QuantStudio 7 Pro (Thermo Fisher).

Lyra Direct is available now in the U.S.

Quidel clearance signals arrival of rapid antigen tests for coronavirus
Clearance of Quidel's rapid antigen diagnostic test by the U.S. Food and Drug Administration marks the arrival of a third type of assay for the novel...
Quidel receives expanded approval for COVID-19 test
The U.S. Food and Drug Administration has expanded Quidel's emergency use authorization for the company's Lyra SARS-CoV-2 assay, a real-time reverse transcription...
Molecular testing and COVID-19: Where are we now?
As the COVID-19 pandemic accelerates, attention has been focused on how to effectively scale up the diagnostic testing that is needed to correctly manage...
FDA hosts town hall on diagnostic testing for novel coronavirus
The U.S. Food and Drug Administration (FDA) will host a virtual town hall on March 25 for clinical laboratories and commercial manufacturers to discuss...
Quidel coronavirus test granted emergency authorization
Quidel has received emergency use authorization from the U.S. Food and Drug Administration to market its Lyra SARS-CoV-2 assay, a real-time reverse transcription...

Copyright © 2020 LabPulse.com

Last Updated ls 5/19/2020 3:02:09 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current